Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
· Financial Post
VANCOUVER, British Columbia & GRAPEVINE, Texas -- Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2026, and provided a business update. Read More
Visit sportbet.rodeo for more information.